Search Results 881-890 of 17319 for alopecia

1. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Effectiveness of AMG 397 in Subjects With Multiple Myeloma, NHL, and AML - Mayo Clinic

   ... alopecia or toxicities from prior anti-tumor therapy that are considered irreversible (defined as having been present and stable for > 4 weeks prior to ...

2. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

   ... alopecia, vitiligo). Participants with Grade 2 toxicities that are deemed stable or irreversible (e.g., chemotherapy related arthritis or tendinitis, skin ...

3. Symptoms and causes - Mayo Clinic

   There typically are no symptoms in the early stages of bone loss. But once your bones have been weakened by osteoporosis, you might have signs and symptoms that ...

4. Study of bb2121 in Multiple Myeloma - Clinical Trials

   Recovery to ≤ Grade 1 or baseline of any non-hematologic toxicities due to prior treatments, excluding alopecia and Grade 2 neuropathy. * True abstinence ...

5. Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects with Nonresectable or Metastatic IDH1-Mutant Cholangiocarcinoma - Mayo Clinic

   Residual Grade ≤ 2 toxicity from chemotherapy (e.g., alopecia, neuropathy) may be allowed. Major surgery within 4 weeks prior to the first IMP ...

6. Nutrition and healthy eating Nutrition basics - Mayo Clinic

   You can master healthy eating by learning how to plan meals and shop smart, and by practicing healthy-cooking techniques.

7. https://www.mayoclinic.org/spanish_patient_consumer_video.xml

8. https://www.mayoclinic.org/arabic_patient_consumer_video.xml

9. MEDI5395 Advanced Solid Tumors - Clinical Trials

   Participation eligibility · Vitiligo or alopecia; · Hypothyroidism (e.g., following Hashimoto syndrome) stable on hormone replacement; · Any chronic skin condition ...

10. https://www.mayoclinic.org/spanish_patient_consumer_recipe.xml